Item 8.01. Other Events

On January 10, 2023, Revelation Biosciences, Inc. (the "Company") issued a press release, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K, announcing that, on January 13, 2023, the Company's units, which trade with the ticker symbol "REVBU" will be mandatorily separated and the units will no longer trade on the Nasdaq Capital Market. Each unit is comprised of one share of the Company's common stock and one warrant that entitles the holder to purchase one share of common stock at price of $11.50 per share. In the separation, unit owners will receive the number of shares of common stock and warrants underlying such units. This is a mandatory and automatic separation, and no action is required by the holders of units.

The common stock and warrants are listed on the Nasdaq Capital Market and trade with the ticker symbols "REVB" and "REVBW", respectively.

Item 9.01. Financial Statements and Exhibits

(d) Exhibits.



  99.1       Press release dated January 10, 2023
104        Cover Page Interactive Data File (embedded within the Inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses